Subscribe To
Mydecine innovations announces appointment of dr victoria hale to the company's board of directors
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors. The comp...
February 3, 2022, 8:40 am
Mydecine innovations announces appointment of dr victoria hale to the company's board of directors
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors. The comp...
February 3, 2022, 8:40 am
Mydecine innovations announces appointment of dr victoria hale to the company's board of directors
Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors. The comp...
February 3, 2022, 8:40 am
Graybug to participate in three upcoming medical and investor conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...
February 3, 2022, 7:30 am
Graybug to participate in three upcoming medical and investor conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...
February 3, 2022, 7:30 am
Graybug to participate in three upcoming medical and investor conferences
BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...
February 3, 2022, 7:30 am
Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...
February 3, 2022, 7:05 am
Here's what to like about johnson & johnson's q4 update
The pharmaceutical segment continues to be J&J's biggest growth driver....
February 3, 2022, 7:05 am
Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...
February 3, 2022, 7:05 am
Here's what to like about johnson & johnson's q4 update
The pharmaceutical segment continues to be J&J's biggest growth driver....
February 3, 2022, 7:05 am
Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...
February 3, 2022, 7:05 am
Here's what to like about johnson & johnson's q4 update
The pharmaceutical segment continues to be J&J's biggest growth driver....
February 3, 2022, 7:05 am
West to host fourth-quarter and full-year 2021 conference call
EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...
February 3, 2022, 6:00 am
West to host fourth-quarter and full-year 2021 conference call
EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...
February 3, 2022, 6:00 am
West to host fourth-quarter and full-year 2021 conference call
EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...
February 3, 2022, 6:00 am
Covid becoming endemic will require need for testing in future, roche ceo says
Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...
February 3, 2022, 4:13 am
Covid becoming endemic will require need for testing in future, roche ceo says
Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...
February 3, 2022, 4:13 am
Covid becoming endemic will require need for testing in future, roche ceo says
Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...
February 3, 2022, 4:13 am
Arrowhead pharmaceuticals, inc. (arwr) ceo dr. christopher anzalone on q1 2022 results - earnings call transcript
Arrowhead pharmaceuticals, Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call ...
February 2, 2022, 9:40 pm
Arrowhead pharmaceuticals, inc. (arwr) ceo dr. christopher anzalone on q1 2022 results - earnings call transcript
Arrowhead pharmaceuticals, Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call ...
February 2, 2022, 9:40 pm